Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant Trials - Concepedia

Concepedia

Publication | Open Access

Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant Trials

DOI Full Paper Access

167

Citations

44

References

2020

Year

Romain Cohen, Jack Fiskum, Greg Yothers, Richard M. Goldberg, Takayuki Yoshino, Steven R. Alberts, Carmen J. Allegra, Aimery de Gramont, J. F. Seitz, Michael J. O’Connell,

Journal of Clinical Oncology

Abstract

Adding oxaliplatin to FP improves OS and DFS in patients with MSI stage III CC. Compared with MSS, MSI patients experienced better outcomes in the N1 group but similar survival in the N2 group.

References

	Year	Citations

Page 1